<!-- KEYWORD_LINKING_METADATA:
{
  "processed_timestamp": "2025-09-24T15:15:34.992187",
  "vocabulary_version": "1.0",
  "selected_keywords": [
    "Bayesian Calibration",
    "Surrogate Models",
    "Model Discrepancy",
    "Glioblastoma Progression"
  ],
  "rejected_keywords": [],
  "similarity_scores": {
    "Bayesian Calibration": 0.82,
    "Surrogate Models": 0.8,
    "Model Discrepancy": 0.79,
    "Glioblastoma Progression": 0.77
  },
  "extraction_method": "AI_prompt_based",
  "budget_applied": true,
  "candidates_json": {
    "candidates": [
      {
        "surface": "Bayesian calibration",
        "canonical": "Bayesian Calibration",
        "aliases": [
          "Bayesian parameter estimation"
        ],
        "category": "specific_connectable",
        "rationale": "Bayesian calibration is crucial for parameter estimation in complex models, enhancing connectivity with statistical modeling techniques.",
        "novelty_score": 0.55,
        "connectivity_score": 0.78,
        "specificity_score": 0.72,
        "link_intent_score": 0.82
      },
      {
        "surface": "surrogate models",
        "canonical": "Surrogate Models",
        "aliases": [
          "approximate models",
          "meta-models"
        ],
        "category": "specific_connectable",
        "rationale": "Surrogate models are pivotal in reducing computational cost, linking to efficiency improvements in model simulations.",
        "novelty_score": 0.6,
        "connectivity_score": 0.75,
        "specificity_score": 0.7,
        "link_intent_score": 0.8
      },
      {
        "surface": "model discrepancy",
        "canonical": "Model Discrepancy",
        "aliases": [
          "model error",
          "model bias"
        ],
        "category": "unique_technical",
        "rationale": "Understanding model discrepancy is essential for refining models, offering unique insights into model limitations.",
        "novelty_score": 0.65,
        "connectivity_score": 0.7,
        "specificity_score": 0.78,
        "link_intent_score": 0.79
      },
      {
        "surface": "glioblastoma progression",
        "canonical": "Glioblastoma Progression",
        "aliases": [
          "brain tumor growth"
        ],
        "category": "unique_technical",
        "rationale": "Glioblastoma progression is a specific biological process that connects to medical and biological research on cancer.",
        "novelty_score": 0.68,
        "connectivity_score": 0.65,
        "specificity_score": 0.8,
        "link_intent_score": 0.77
      }
    ],
    "ban_list_suggestions": [
      "computational models",
      "parameter probability distributions",
      "predictive performance"
    ]
  },
  "decisions": [
    {
      "candidate_surface": "Bayesian calibration",
      "resolved_canonical": "Bayesian Calibration",
      "decision": "linked",
      "scores": {
        "novelty": 0.55,
        "connectivity": 0.78,
        "specificity": 0.72,
        "link_intent": 0.82
      }
    },
    {
      "candidate_surface": "surrogate models",
      "resolved_canonical": "Surrogate Models",
      "decision": "linked",
      "scores": {
        "novelty": 0.6,
        "connectivity": 0.75,
        "specificity": 0.7,
        "link_intent": 0.8
      }
    },
    {
      "candidate_surface": "model discrepancy",
      "resolved_canonical": "Model Discrepancy",
      "decision": "linked",
      "scores": {
        "novelty": 0.65,
        "connectivity": 0.7,
        "specificity": 0.78,
        "link_intent": 0.79
      }
    },
    {
      "candidate_surface": "glioblastoma progression",
      "resolved_canonical": "Glioblastoma Progression",
      "decision": "linked",
      "scores": {
        "novelty": 0.68,
        "connectivity": 0.65,
        "specificity": 0.8,
        "link_intent": 0.77
      }
    }
  ]
}
-->

# Bayesian Calibration and Model Assessment of Cell Migration Dynamics with Surrogate Model Integration

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily_digest_20250924|20250924]] [[categories/cs.LG|cs.LG]]
**PDF**: [Download](https://arxiv.org/pdf/2509.18998.pdf)
**Category**: cs.LG
**Published**: 2025-09-24
**ArXiv ID**: [2509.18998](https://arxiv.org/abs/2509.18998)

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[2025-09-23/Addressing the Inconsistency in Bayesian Deep Learning via Generalized Laplace Approximation_20250923|Addressing the Inconsistency in Bayesian Deep Learning via Generalized Laplace Approximation]] (81.6% similar)
- [[2025-09-24/Surrogate Modelling of Proton Dose with Monte Carlo Dropout Uncertainty Quantification_20250924|Surrogate Modelling of Proton Dose with Monte Carlo Dropout Uncertainty Quantification]] (81.5% similar)
- [[2025-09-23/An AI-powered Bayesian generative modeling approach for causal inference in observational studies_20250923|An AI-powered Bayesian generative modeling approach for causal inference in observational studies]] (81.5% similar)
- [[2025-09-24/Accounting for Uncertainty in Machine Learning Surrogates_ A Gauss-Hermite Quadrature Approach to Reliability Analysis_20250924|Accounting for Uncertainty in Machine Learning Surrogates: A Gauss-Hermite Quadrature Approach to Reliability Analysis]] (80.9% similar)
- [[2025-09-23/Enhancing Performance and Calibration in Quantile Hyperparameter Optimization_20250923|Enhancing Performance and Calibration in Quantile Hyperparameter Optimization]] (80.5% similar)

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸ”— Specific Connectable**: [[keywords/Bayesian Calibration|Bayesian Calibration]], [[keywords/Surrogate Models|Surrogate Models]]
**âš¡ Unique Technical**: [[keywords/Model Discrepancy|Model Discrepancy]], [[keywords/Glioblastoma Progression|Glioblastoma Progression]]

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2509.18998v1 Announce Type: cross 
Abstract: Computational models provide crucial insights into complex biological processes such as cancer evolution, but their mechanistic nature often makes them nonlinear and parameter-rich, complicating calibration. We systematically evaluate parameter probability distributions in cell migration models using Bayesian calibration across four complementary strategies: parametric and surrogate models, each with and without explicit model discrepancy. This approach enables joint analysis of parameter uncertainty, predictive performance, and interpretability. Applied to a real data experiment of glioblastoma progression in microfluidic devices, surrogate models achieve higher computational efficiency and predictive accuracy, whereas parametric models yield more reliable parameter estimates due to their mechanistic grounding. Incorporating model discrepancy exposes structural limitations, clarifying where model refinement is necessary. Together, these comparisons offer practical guidance for calibrating and improving computational models of complex biological systems.

## ğŸ“ ìš”ì•½

ì´ ë…¼ë¬¸ì€ ì•” ì§„í™”ì™€ ê°™ì€ ë³µì¡í•œ ìƒë¬¼í•™ì  ê³¼ì •ì„ ì´í•´í•˜ëŠ” ë° ì¤‘ìš”í•œ ê³„ì‚° ëª¨ë¸ì˜ ë§¤ê°œë³€ìˆ˜ ë¶ˆí™•ì‹¤ì„±ì„ í‰ê°€í•˜ëŠ” ë°©ë²•ì„ ì œì‹œí•©ë‹ˆë‹¤. ì €ìë“¤ì€ ì„¸í¬ ì´ë™ ëª¨ë¸ì˜ ë§¤ê°œë³€ìˆ˜ í™•ë¥  ë¶„í¬ë¥¼ ë² ì´ì§€ì•ˆ ë³´ì •ì„ í†µí•´ ë„¤ ê°€ì§€ ì „ëµìœ¼ë¡œ í‰ê°€í–ˆìŠµë‹ˆë‹¤. ì‹¤í—˜ì—ì„œëŠ” ë¯¸ì„¸ìœ ì²´ ì¥ì¹˜ì—ì„œì˜ êµëª¨ì„¸í¬ì¢… ì§„í–‰ ë°ì´í„°ë¥¼ ì‚¬ìš©í–ˆìœ¼ë©°, ëŒ€ë¦¬ ëª¨ë¸ì€ ê³„ì‚° íš¨ìœ¨ì„±ê³¼ ì˜ˆì¸¡ ì •í™•ë„ê°€ ë†’ì•˜ê³ , ë§¤ê°œë³€ìˆ˜ ëª¨ë¸ì€ ì‹ ë¢°í•  ìˆ˜ ìˆëŠ” ë§¤ê°œë³€ìˆ˜ ì¶”ì •ì¹˜ë¥¼ ì œê³µí–ˆìŠµë‹ˆë‹¤. ëª¨ë¸ ë¶ˆì¼ì¹˜ë¥¼ í¬í•¨í•˜ë©´ êµ¬ì¡°ì  í•œê³„ë¥¼ ë“œëŸ¬ë‚´ì–´ ëª¨ë¸ ê°œì„ ì´ í•„ìš”í•œ ë¶€ë¶„ì„ ëª…í™•íˆ í•  ìˆ˜ ìˆì—ˆìŠµë‹ˆë‹¤. ì´ëŸ¬í•œ ë¹„êµëŠ” ë³µì¡í•œ ìƒë¬¼í•™ì  ì‹œìŠ¤í…œì˜ ê³„ì‚° ëª¨ë¸ ë³´ì • ë° ê°œì„ ì— ì‹¤ì§ˆì ì¸ ì§€ì¹¨ì„ ì œê³µí•©ë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. ì»´í“¨í„° ëª¨ë¸ì€ ì•” ì§„í™”ì™€ ê°™ì€ ë³µì¡í•œ ìƒë¬¼í•™ì  ê³¼ì •ì„ ì´í•´í•˜ëŠ” ë° ì¤‘ìš”í•œ í†µì°°ë ¥ì„ ì œê³µí•˜ì§€ë§Œ, ë¹„ì„ í˜•ì„±ê³¼ ë§ì€ ë§¤ê°œë³€ìˆ˜ë¡œ ì¸í•´ ë³´ì •ì´ ë³µì¡í•˜ë‹¤.
- 2. ë² ì´ì§€ì•ˆ ë³´ì •ì„ í†µí•´ ì„¸í¬ ì´ë™ ëª¨ë¸ì˜ ë§¤ê°œë³€ìˆ˜ í™•ë¥  ë¶„í¬ë¥¼ í‰ê°€í•˜ë©°, ëª…ì‹œì  ëª¨ë¸ ë¶ˆì¼ì¹˜ ì—¬ë¶€ì— ë”°ë¼ ë„¤ ê°€ì§€ ì „ëµì„ ì‚¬ìš©í•œë‹¤.
- 3. ëŒ€ë¦¬ ëª¨ë¸ì€ ê³„ì‚° íš¨ìœ¨ì„±ê³¼ ì˜ˆì¸¡ ì •í™•ë„ì—ì„œ ìš°ìˆ˜í•œ ì„±ëŠ¥ì„ ë³´ì´ë©°, ë§¤ê°œë³€ìˆ˜ ëª¨ë¸ì€ ê¸°ê³„ì  ê¸°ë°˜ìœ¼ë¡œ ì¸í•´ ë” ì‹ ë¢°í•  ìˆ˜ ìˆëŠ” ë§¤ê°œë³€ìˆ˜ ì¶”ì •ì¹˜ë¥¼ ì œê³µí•œë‹¤.
- 4. ëª¨ë¸ ë¶ˆì¼ì¹˜ë¥¼ í¬í•¨í•˜ë©´ êµ¬ì¡°ì  í•œê³„ë¥¼ ë“œëŸ¬ë‚´ì–´ ëª¨ë¸ ê°œì„ ì´ í•„ìš”í•œ ë¶€ë¶„ì„ ëª…í™•íˆ í•œë‹¤.
- 5. ì´ëŸ¬í•œ ë¹„êµëŠ” ë³µì¡í•œ ìƒë¬¼í•™ì  ì‹œìŠ¤í…œì˜ ì»´í“¨í„° ëª¨ë¸ ë³´ì • ë° ê°œì„ ì„ ìœ„í•œ ì‹¤ì§ˆì ì¸ ì§€ì¹¨ì„ ì œê³µí•œë‹¤.


---

*Generated on 2025-09-24 15:15:34*